drugset / Trial / NCT03388814
Speeding Recovery From Pain and Opioid Use
RandomizedParallel-groupDouble-blindPrevention
Summary
Surgical treatment of breast cancer is associated with significant disability, and pain is often reported as a primary cause for declines in the ability to perform activities of daily living. However, breast reconstruction at the same time as mastectomy has been linked to higher postoperative pain, which can be a risk factor for persistent pain. The goal of this study is to determine the speed of recovery from pain and opioid use in the first 2 months after breast surgery and reconstruction.
Timeline
- Start
- 2018-11
- Primary completion
- 2020-06
- Completion
- 2020-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Comparator | Bupivacaine | Other / unclassified | 30 ml | Other |
| Background | Clonidine | Other / unclassified | 1.67 ug/ml | Other |
| Background | Epinephrine | Other / unclassified | — | Other |